journavx pain management - Search News

FDA approves new pain medicine

U.S. News & World Report · 1d

What to Know About Journavx, the Non-Opioid Pain Medication Just Approved by the FDA

The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in more than 20 years.

Hosted on MSN · 1d

FDA approves new pain medicine as opioid alternative. What to know about Journavx

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side effects.

The Washington Post · 1d

FDA approves new, non-opioid painkiller Journavx

The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller to win FDA approval in more than 20 years.

1d

FDA approves opiate-alternative acute pain management drug, local experts share their thoughts

On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare ...

FDA approves nonopioid Journavx for moderate to severe acute pain

The FDA has approved Journavx 50 mg oral tablets for the treatment of moderate to severe acute pain in adults, according to a ...

Psychology Today1d

Treating Pain—Avoiding the Brain

A new class of non-opioid drugs treats pain by blocking signals before they reach the brain, reducing the risk of addiction.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results